Top-News

Creative Medical Technology Holding News

Keine aktuellen Kursdaten verfügbar
ISIN: US22529Y1010
US-Symbol: CELZ
Typ: Aktie

Creative Medical Technology Holding News

15.11.23 - PR Newswire
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings Provides Corporate Update PR Newswire
10.10.23 - PR Newswire
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to ...
19.09.23 - PR Newswire
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic ...
13.09.23 - PR Newswire
Thinking about buying stock in AMC Entertainment Holdings, Creative Medical Technology Holdings, Scienjoy Holding, Aurora Cannabis, or Novo Integrated Sciences?
Thinking about buying stock in AMC Entertainment Holdings, Creative Medical Technology Holdings, Scienjoy Holding, Aurora Cannabis, or Novo Integrated Sciences? PR Newswire
28.06.23 - PR Newswire
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements PR Newswire
12.06.23 - PR Newswire
Creative Medical Technology Announces $2 Million Share Repurchase Program
Creative Medical Technology Announces $2 Million Share Repurchase Program PR Newswire
12.06.23 - PR Newswire
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings Provides Corporate Update PR Newswire
09.06.23 - PR Newswire
Creative Medical Technology Holdings Announces Reverse Stock Split
Creative Medical Technology Holdings Announces Reverse Stock Split PR Newswire
22.05.23 - PR Newswire
Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development
Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development PR Newswire
18.05.23 - PR Newswire
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell ...
12.04.23 - PR Newswire
Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic?
Thinking about buying stock in Newmark Group, Exscientia, Pardes Biosciences, Creative Medical Technology, or Somalogic? PR Newswire
12.04.23 - PR Newswire
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study PR Newswire
23.03.23 - PR Newswire
Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes
Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes PR Newswire
21.03.23 - PR Newswire
Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development
Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development PR Newswire
08.02.23 - PR Newswire
Thinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL?
Thinking about buying stock in Creative Medical, Meta, Advanced Micro Devices, Carvana, or SeqLL? PR Newswire
08.02.23 - PR Newswire
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of Novel Cell Therapy for the Treatment of Type 1 Diabetes PR Newswire
03.11.22 - PR Newswire
Thinking about buying stock in Roku, Peloton, Mullen Automotive, Creative Medical Technology, or Marathon Oil?
Thinking about buying stock in Roku, Peloton, Mullen Automotive, Creative Medical Technology, or Marathon Oil? PR Newswire
03.11.22 - PR Newswire
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 ...
20.10.22 - PR Newswire
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line PR Newswire
26.09.22 - PR Newswire
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study PR Newswire

Newssuche

Videos

newspaper
26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »